Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
Saved in:
Becker, W.C., et al., Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Journal of Substance Abuse Treatment, vol. 48, 2015, p. 128-131.
Ref.
500581
Location:
SIIS R.991 Archivo
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Reducción de daños, Programas de mantenimiento, Buprenorfina, Efectos, Dolor
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Reducción de daños, Programas de mantenimiento, Buprenorfina, Efectos, Dolor
Similar Items: Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder
- PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
- Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder
- THRICE WEEKLY SUPERVISED DOSING WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET IS PREFERRED TO DAILY SUPERVISED DOSING BY OPIOID-DEPENDET HUMANS
- PAIN AND SUBSTANCE-RELATED PAIN-REDUCTION BEHAVIORS AMONG OPIOID DEPENDENT INDIVIDUALS SEEKING METHADONE MAINTENANCE TREATMENT
- EFFICACY OF DAILY AND ALTERNATE-DAY DOSING REGIMENS WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET
- OPIOID DETOXIFICATION WITH BUPRENORPHINE, CLONIDINE, OR METHADONE IN HOSPITALIZED HEROIN-DEPENDENT PATIENTS WITH HIV INFECTION